chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt recvd Engerix-B vax 02AUG91 & 3 days later pt exp general flu-like illness, severe h/a, neck stiffness, & photophobia; dx of meningitis was considered; MD felt pt exp "allergic meningoencephalitis";
This spontaneous report was received from a medical assistant and refers to a 2 month old female patient. The patient had no pertinent medical history and drug reactions or allergies. She had no concomitant medications. On 03-MAY-2016, the patient was vaccinated with the first dose of ROTATEQ (lot #L029615, expiration date: 15-MAY-2017, dose was not provided). On 03-MAY-2016, immediately following the administration of ROTATEQ the patient vomited. There was no lab diagnostic studies performed. The patient sought medical attention as the adverse event occurred in the office. No treatment was given for the adverse event. The outcome of the event was reported as recovered, on 03-MAY-2016. The relatedness between the event and ROTATEQ was not provided. Additional information has been requested.
Patient in office, received 4 month old vaccines. Twenty minutes after receiving Rotateq vaccine, patient vomited. Patient vomited a total of 7 times.
elevated blood pressure; red cheeks; rash; peeling of skin; sizzling; upset stomach; burning; lightheaded; achy; tingling; This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th October 2019, the patient received the 1st dose of Shingrix. On 12th October 2019, 5 days after receiving Shingrix, the patient experienced increased blood pressure and red face. In October 2019, the patient experienced injection site rash, skin peeling, tingling, extremities hot feeling of, upset stomach, burning sensation, light headedness and general body pain. On 18th October 2019, the outcome of the increased blood pressure and red face were recovered/resolved. On an unknown date, the outcome of the injection site rash and skin peeling were not recovered/not resolved and the outcome of the tingling, upset stomach, burning sensation, light headedness and general body pain were recovered/resolved and the outcome of the extremities hot feeling of was unknown.   The reporter considered the injection site rash, skin peeling, tingling, upset stomach, burning sensation, light headedness, general body pain, increased blood pressure and red face to be related to Shingrix. It was unknown if the reporter considered the extremities hot feeling of to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on left deltoid. Less than 3 weeks after receiving Shingrix, within days of the first injection, the patient developed a rash around the injection site which had just started to fade at the reporting date. The skin was peeling off.  The patient also experienced tingling going down her left leg, almost like a sizzling.  The patient had an upset stomach, some burning and lightheartedness as well as body aches. All symptoms with the exception of the rash and tingling resolved within a few days. The tingling down her leg went away about a week and a half after the shot.  The patient called back later to add her blood pressure went as high as 156/84 mm Hg and her facial cheeks were red. The reporter consented to follow up.
Narrative:  COVID infection following COVID vaccine series 02/09, Pfizer, dose #1 03/01, Pfizer, dose #2 BNP: 81.5 10/31 CXR impression: No acute cardiopulmonary disease. 10/31 SARS-COV-2 Variant Sequencing RESULT:pending 10/31 PROCALCITONIN: <0.05 10/31 pt cc: cough, exposure: unknown 10/31 CRP: 1.358 10/31 COVID swab, result: detected 10/31 PT/APTT/INR: 11/6/30.0/1.04 10/31 DDIMER: 0.52 11/02 pt admit to ED cc: cough, dx: COVID-19+ LOS: 1 DAY 11/12 COVID swab, result: detected
I had a very bad cough, headache, and sniffles. I felt bad for a week and a half. I tested positive for COVID-19 at home. I talked to my doctor, and he prescribed me PAXLOVID. I was still feeling bad so I asked my doctor if I can also take something over the counter, which I did. I was sick for most of January because I caught a cold as well.
Rt arm raised welp. Red and itching. Little larger than the size of a palm.
pt recv vax & exp thrombocytopenic purpura;@ the time of report, pt was 11 yr old;no further details were provided;
Initial report received on 25 July 2012 from the Investigator participating in the post-marketing study under the reference number M5A16. A case of pertussis disease in a 2-year-old male subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDS) electronic database. The subject had received 3 doses of PENTACEL; lot number C3195AA received on 13 November 2009, lot number C3198AA received on 11 January 2010, lot number C3494AA received on 31 March 2010, and a dose of DAPTACEL, lot number C3449BA on 11 April 2011 (routes and sites of administration not reported). The subject developed a cough on 06 June 2012, approximately 13 months after the last dose. On 12 June 2012, the subject developed a paroxysmal cough with a whoop. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 13 June 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 13 June 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 29 June 2012, the subject's cough had resolved. The duration of the cough was reported at that time as 18 days. Investigator causality assessment is not required per protocol. Documents held by sender: None.
Body aches, severe fatigue, Temp 101.2F, persistent head ache, slight nausea. Symptoms resolved by post-vaccine day 3.
The next day, I experienced pain in the left arm and shoulder (near injection site), severe headache, and confusion.
pt recv vax 22JAN97 & 15NOV97 pt devel a severe case of chickenpox;
Fatigue, Chills, headache, sore arm. The sore arm lasted a couple of days. The other symptoms went away after 24h.
a booster vaccine was given to a patient who is 9 years old, when boosters are not yet recommended/authorized for this age grou p
B cell lymphoma, atrophy, anemia, blockage in small intestine, fast heart rate, death
Thrombocytopenia to 98. Incidental finding. Repeat on 3/18  was 120. Smear unremarkable.
arm is swollen; hard; pinkish red 2 inches above her elbow; whole body ached; headache; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (whole body ached), HEADACHE (headache), PERIPHERAL SWELLING (arm is swollen), INDURATION (hard) and ERYTHEMA (pinkish red 2 inches above her elbow) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL ALLERGY & SINUS) for Sinus pain.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN (whole body ached) and HEADACHE (headache). On 22-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm is swollen), INDURATION (hard) and ERYTHEMA (pinkish red 2 inches above her elbow). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 21-Feb-2021, PAIN (whole body ached) and HEADACHE (headache) had resolved. At the time of the report, PERIPHERAL SWELLING (arm is swollen), INDURATION (hard) and ERYTHEMA (pinkish red 2 inches above her elbow) outcome was unknown.            patient has taken concomitant medication for rheumatoid Arthritis and bone injection,reason was not specified
Covid 19 Moderna 2nd shot. Body aches , chills and 104 fever
Patient developed 4-6 inch approx. erythematous rash within 2 hours of vaccination.  Swelling  was significant. Symptoms persisted to 72 hours.
shingles close to my eye; didnt want the second dose; so sick; This case was reported by a consumer via  interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles, sickness and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown and the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the shingles and sickness to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported. The patient received Shingrix vaccine and was very sick for approximately 6 weeks with shingles close to her/his eye. The patient was so sick and decided did not want the second dose and till the time of reporting, the patient wished if he/she had received 2nd dose, which led to incomplete course of vaccination. The follow up would not be possible as no contact details were available.
(L) arm red swollen warm to touch about five inches long. Sore painful to touch. Took 10 days to totally feel better. Got a little better each day.
Short term: Fatigue (4 days), debilitating fever and chills (2 days), white and purple extremities (3 hours), severe chest/abdomen pain and pressure (1 day) - nearly went to ER  Longer term: headaches (1 week), halted menstrual cycle with no pregnancy (1 week late on clockwork 26 day cycle with no stress or lifestyle changes.)
I was vaccinated on 4/20/2021. When I woke up on the morning of 4/22/2021, I had a really bad headache, a sore right shoulder. I had problems with my bowels, with intermittent constipation and diarrhea. The headache and bowel issues lasted for a couple of months, but they eventually subsided. The sore shoulder lasted for only a week or so. I called my doctor. I was told the symptoms were pretty standard and that I had no reason to worry.
5 hours after vaccine administration, mother noticed significant facial edema beginning in periorbital and maxillary areas. Edema was dependent. The following day, mother noticed  swelling in hands, lips, and neck areas. Day 2, edema extended into lower limbs based on positioning. Vital signs have remained stable, and no additional oxygen support has been needed. Closely monitored for pulmonary edema d/t history. Diuresing excessively.
bruise on left leg about the size of quarter and reddish blue in color; feels lump under the bruise; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruise on left leg about the size of quarter and reddish blue in color) and HAEMATOMA (feels lump under the bruise) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced CONTUSION (bruise on left leg about the size of quarter and reddish blue in color) and HAEMATOMA (feels lump under the bruise). At the time of the report, CONTUSION (bruise on left leg about the size of quarter and reddish blue in color) and HAEMATOMA (feels lump under the bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
+ COVID 19 test fever, worsening shortness of breath, cough, decreased appetite, generalized weakness/fatigue,
Pt developed red, raised, painful area anterior Rt upper arm, at site of flu and pneumococcal vac., area 6 x 7 cm. States both vac. given Rt arm.
several vaccine preparations come in powdered form in a vile with the diluent in a separate vial. Frequently, staff will unbox these items and place them in trays in the medication refrigerator for easy, rapid access. On more than one occasion, it has been discovered that there are more powdered vials than diluents in the refrigerator. We suspect that medical assistants may be grabbing and administering the diluent, not aware that there is a powdered drug. Often the diluent and powdered vials are the same size, same type lettering, color, etc. See Menomune.
No additional AE reported; PROQUAD underwent a temperature excursion; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.   On 12-AUG-2021, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # U002538, expiration date 24-JUL-2022, 0.5 milliliter) for prophylaxis (product storage error). Temperature excursion was 5.7 Fahrenheit degree for 10 minutes. There was no previous temperature excursion. No additional AE was reported.
paresthesia in my right leg and it moved to both legs, arms, and hands; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious) with onset 26Feb2021, outcome "unknown", described as "paresthesia in my right leg and it moved to both legs, arms, and hands".  Additional Information: The patient experienced paresthesia in his right leg and it moved to both legs, arms, and hands, within 10 min after vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
returned to work past injection in evening started itching all over and SOB states was dizzy, felt heart pounding called and reported this on 10/27/08 states she then took a benadryl and went to sleep. states woke up again next morning felt better but remained nauseated and SOB but felt this was related to her hx of asthma. Has a Doctor appt on 10/29/08.
Patient broke out in a rash on her leg the day after her second vaccine and we treated it for dermatitis until the rash didn't improve, she complained of pain, and we went to her PCP for help. She diagnosed her with shingles and stared taking an anti-viral med and nerve pain med. Her rash is almost dried up and nerve pain is now minimal.
Increasing apneas requiring septic work-up/antibiotics. Symptom started about25 hours after DTaP/IPV. Blood//urine cultures negative.  4/4/08 Reviewed hospital medical records of 11/8-12/04/2007.  Patient transferred to outlying birth hospital on 12/4/07 w/interim d/c summary dated 3/14/08. FINAL DX: cardiac arrest 11/8; extreme prematurity; RDS; chronic lung disease; PDA; pulmonary interstitial emphysema; seizures; IVH; ROP; anemia; thrombocytopenia, adrenal insufficiency; hypotension,hyperbilirubinemia, electrolyte instability, coagulopathy, metabolic acidosis, all resolved; coag-neg staph bacteremia, resolving. Records reveal patient had been transferred from outlying birth hospital at 10 days of age for PDA ligation on 11/9.  Patient experienced multiple problems associated w/extreme prematurity.  Transfused w/multiple blood products.  Stabilized & returned to birth hospital on 12/4/2007.  Records from birth hospital that accompanied VAERS report reveal patient experienced hyponatremia at time of vaccination on 12/28 & 12/29.  Dx w/newborn sepsis on 12/30.  4/18/08 Reviewed hospital medical records for 12/4/07-03/19/2008. FINAL DX: 23 wk preemie, anemia of prematurity, ROP, SGA, at risk RSV.                          4/29/08 Reviewed hospital records for 12/28/2007-1/5/2008 including vax record for 12/28 & 12/29/2007. Records reveal patient continued on CPAP & caffiene for apnea since 11/22, last apnea noted 12/27, mostly self resolved.  Was on Pb for seizures, last seizure noted 11/26.  Had increased apneas overnight 12/29-30.  Caffiene & high flow nasal cannula increased.  Started IV antibiotics on 12/31 for increased CRP of 2.6  & presumed sepsis.  Transfused 12/31.  CRP 0.94 on 1/2/08.  6 apnea spells 1/3-1/4/2008 w/probable reflux.  CRP 1/4 0.23.
Child rec'd varicella vxn  (per non card) at pediatrician 8/19/02. Seen today (8/15/06) for fever, vesicular rash w/ secondary impetigo. Diagnosed w/ breakthrough varicella w/ 2 hrs impetigo.
Information has been receive from a Licensed Practical Nurse (L.P.N.) referring to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On multiple unspecified dates, the patients were vaccinated with improperly stored PEDVAXHIB (dose, lot # and route unspecified). Information regarding concomitant medications was not reported. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Onset of pallor, sweating, cough and mild shortness of breath.  Epi-pen administered,  Albuterol via nebulizer.  911 called and transported to Emergency Room.  BP was stable throughout.  O2 sat maintained. No need for oxygen
Information has been received from a registered nurse referring to a 5 year old male patient. The patient's medical history was not reported. On 04-MAY-2015 the patient was vaccinated with improperly stored PROQUAD (Merck) injection lot # K022447, exp 13-MAY-2016, 0.5 ml, subcutaneously in the right leg. No adverse effects reported at this time. No concomitant medication was reported. Action taken and outcome were not provided. This is one of several reports from the same source. Additional information has been requested.
Pt came to clinic on 28 Jan 10 for a tetanus shot but received a flu shot. Pt states the next day she started getting red blotches around the injection site. Used BENADRYL and blotches subsided within 24 hrs.
62 year old male presented for 1st dose COVID vaccine with pfizer. 15-minutes post-vaccination the patient complained of having a minor headache. At this time he expressed no other concerns or symptoms. The patient was moved to a shaded area and provided water. Upon further questioning in Spanish the patient reported that his HA was progressively worsening since onset and he had an associated "tightness" and sensation of a growing lump in his throat. Patient denied SOB, chest tightness, difficulty breathing, itching, hives, lightheadedness, N/V. At this time the decision was made to contact EMS. EMS arrived at 1804 and evaluated the patient. During evaluation the patient reported improvement of his HA and throat discomfort. EMS instructed patient to be evaluated at the local ER. However, the patient refused and signed to leave AMA. Patient left the site at 1825 and stated he would take the bus home. Education was provided and patient instructed to follow-up in ER if symptoms re-emerge.
Tinnitis beginning evening of or day after administration of vaccine. Continual since then. Manifests as a constant whine.
Simple febrile seizure within 12 hrs. of receiving PCV13, flu, Hep A & HIB vaccines.
The patient received the wrong vaccine; instead of receiving the monovalent dose, they received a bivalent dose as the first dose.  No signs or symptoms,
By 7:30 that same evening I had the chills which lasted until 12:30 AM. I would fall asleep and wake up with chills - shivering couldn't stop. Took 2 Extra Strength TYLENOL. Spoke with doctor next day.
SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT Initial report received on 25 July 2007 from a health care professional. A 13-year-old female patient, who had a history of a prior evaluation for multiple sclerosis, had received an intramuscular, left deltoid injection of Adacel, lot number C2720AA; a first dose, intramuscular, right deltoid injection of Menactra, lot number U2069AA; a first dose, subcutaneous, left arm injection of Varivax, manufacturer  Merck, lot number 0598U; and a first dose, intramuscular, right deltoid injection of Havrix, manufacturer GSK, lot number AHAZB162CB; on 16 July 2007. Three days later, the patient experienced "left sided numbness and tingling from head to toe along lateral aspect of the upper and lower extremities." The patient was examined in an emergency room and was scheduled for a neurological evaluation. The patient had a history of headaches and had been evaluated for multiple sclerosis "six to twelve months ago." Test results were negative, and the patient was supposed to have a repeat MRI "six months ago, but never did." Recovery status was unknown. 1/10/08-records received for DOS 7/21-7/24/08-DC DX: left-sided paresthesias/multiple sclerosis flare. Presented with 4 day history of worsening paresthesias on her left side beginning in left hand and progressing into the left leg. Described as tingling and numbness.
flu; Initial information received on 06-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who had flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
The second day after the first shot I started having heart palpitations and it was more noticeable when I sat down or layed down. This lasted for about four days and then went away. After the second shot it lasted for about a day and went away. Four weeks ago my lymph node swelled in my neck and the heart palpitations started again and I had extreme fatigue. I did not get tested for Covid because I have had Covid before and I was immunized.  The heart palpitations are getting better but they still come and go and it has been about four weeks.  The lymph node swelling went down after about a week and the fatigue also went away in about a week
Patient initially received her first dose of Pfizer on 01/14/2021, lot number EK4176. Patient received her follow up vaccination today, which was provided as the Moderna dose, lot number identified above.
Severe headache, sensitivity to light and noise, extreme fatigue, loss of appetite, high fever, up to 102.7. We missed two days of school as of February 12, 2016.
50 year old female patient administered her second dose on 9/25/2021 right arm. Refers having a bump with urticaria of approximate 2 inches in diameter. Area is red and hot to the touch.
4 days after Moderna dose had muscle soreness, back , aching pain, progressed to chills, fever, fatigue, diarrhea, couldn't go to work for 2 more days.  had covid previously 6 months ago and missed 2 weeks of work with persistent fatigue